SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2019.Recent Corporate Updates:Presented early clinical data from the Phase1/2 trial of MRTX849 on

INDIANAPOLIS, Nov. 4, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Credit Suisse 28th Annual Healthcare Conference on Wednesday, November 13, 2019. Anne White, president of Lilly Oncology, Kimberly Blackwell, M.D., vice president, early phase clinical research,

IRVINE, Calif., Nov. 4, 2019 /PRNewswire/ -- Healthpeak Properties, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019) ("Healthpeak") announced today that it has commenced a public offering of an aggregate of 15,000,000 shares of its common stock in connection with the forward sale agreement described below.  The underwriters are expected to be

ROCKVILLE, Md., Nov. 4, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop th

CUPERTINO, Calif., Nov. 4, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended September 30, 2019 and

SEATTLE, Nov. 4, 2019 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the third quarter and nine months ended September 30, 2019."We advanced our pacritinib development program in the third quarter, and recently took an important step forward for the company by initiating and enrolli

GERMANTOWN, Md., Nov. 4, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to seven new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved b

FRISCO, Texas, Nov. 4, 2019 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2019. Net service revenues increased 23.3% for the third quarter to $169.8 million from

SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 28th Annual Credit Suisse Healthcare Conference at The Phoenician in S